Sierakowski S - Search Results

1

[Interstitial lung disease related to systemic connective tissue diseases].

Fiedorczyk M, Rojewska J, Kowal-Bielecka O, Sierakowski S. Fiedorczyk M, et al. Among authors: sierakowski s. Przegl Lek. 2005;62(12):1471-4. Przegl Lek. 2005. PMID: 16786776 Review. Polish.

2

[An up date on pulmonary hypertension related to systemic sclerosis].

Kowal-Bielecka O, Sulik A, Sierakowski S. Kowal-Bielecka O, et al. Among authors: sierakowski s. Przegl Lek. 2005;62(8):813-7. Przegl Lek. 2005. PMID: 16521504 Review. Polish.

3

[Serum tumor necrosis factor alpha (TNF-alpha) concentration correlates with soluble adhesion molecules and vascular endothelial growth factor (VEGF) in rheumatoid arthritis].

Klimiuk PA, Sierakowski S, Fiedorczyk M, Chwiećko J. Klimiuk PA, et al. Among authors: sierakowski s. Przegl Lek. 2004;61(2):86-9. Przegl Lek. 2004. PMID: 15230147 Polish.

4

[Immunopathological disturbances in systemic sclerosis].

Gindzieńska-Sieśkiewicz E, Klimiuk PA, Kowal-Bielecka O, Sierakowski S. Gindzieńska-Sieśkiewicz E, et al. Among authors: sierakowski s. Pol Merkur Lekarski. 2005 Dec;19(114):800-3. Pol Merkur Lekarski. 2005. PMID: 16521427 Review. Polish.

5

[Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].

Fiedorczyk M, Klimiuk PA, Sierakowski S, Kita K. Fiedorczyk M, et al. Among authors: sierakowski s. Pol Merkur Lekarski. 2006 Feb;20(116):228-31. Pol Merkur Lekarski. 2006. PMID: 16708647 Review. Polish.

6

[Cyclophosphamide treatment in patients with systemic sclerosis].

Chwieśko S, Kowal-Bielecka O, Sierakowski S. Chwieśko S, et al. Among authors: sierakowski s. Postepy Hig Med Dosw (Online). 2006;60:300-6. Postepy Hig Med Dosw (Online). 2006. PMID: 16767054 Review. Polish.

7

[Secondary lethal catastrophic antiphospholipid syndrome in 24-years old female patient with overlap syndrome (systemic sclerosis and systemic lupus erythematosus)].

Ciołkiewicz M, Domysławska I, Kita K, Muklewicz E, Kowal-Bielecka O, Lewandowski B, Sierakowski S. Ciołkiewicz M, et al. Among authors: sierakowski s. Pol Merkur Lekarski. 2006 Mar;20(117):337-40. Pol Merkur Lekarski. 2006. PMID: 16780270 Polish.

8

[Correlations between serum matrix metalloproteinase (MMP-1, MMP-3, MMP-9, MMP-13) concentrations and markers of disease activity in early rheumatoid arthritis].

Fiedorczyk M, Klimiuk PA, Sierakowski S, Domysławska I, Chwiećko J. Fiedorczyk M, et al. Among authors: sierakowski s. Przegl Lek. 2005;62(12):1321-4. Przegl Lek. 2005. PMID: 16786739 Polish.

9

[Causes of death of patients with systemic sclerosis].

Chwieśko S, Sierakowski S, Kowal-Bielecka O. Chwieśko S, et al. Among authors: sierakowski s. Pol Merkur Lekarski. 2006 Oct;21(124):341-4. Pol Merkur Lekarski. 2006. PMID: 17205772 Polish.

10

[Serum concentration of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) correlates with markers of the disease activity in early rheumatoid arthritis].

Fiedorczyk M, Klimiuk PA, Sierakowski S, Gińdzieńska-Sieśkiewicz E, Chwiećko J. Fiedorczyk M, et al. Among authors: sierakowski s. Pol Arch Med Wewn. 2006 Jan;115(1):13-7. Pol Arch Med Wewn. 2006. PMID: 17278779 Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters